Zydus Lifesciences Limited - Laporan Laba Rugi (TTM)

Zydus Lifesciences Limited
IN ˙ BSE
₹ 885.45 ↓ -2.25 (-0.25%)
2025-05-02
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Zydus Lifesciences Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 148,501 150,076 144,035 156,130 157,389 157,609 151,099 153,361 157,110 164,335 172,374 184,127 187,760 190,241 195,474 206,153 214,835 222,474 232,415 236,077
Change (%) 1.06 -4.03 8.40 0.81 0.14 -4.13 1.50 2.44 4.60 4.89 6.82 1.97 1.32 2.75 5.46 4.21 3.56 4.47 1.58
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 52,370 52,862 49,434 55,513 56,903 58,363 56,857 58,400 60,734 62,504 64,707 66,358 65,152 64,733 63,937 63,054 63,030 64,179 65,384 67,418
Change (%) 0.94 -6.48 12.30 2.50 2.57 -2.58 2.71 4.00 2.91 3.52 2.55 -1.82 -0.64 -1.23 -1.38 -0.04 1.82 1.88 3.11
% of Revenue 35.27 35.22 34.32 35.56 36.15 37.03 37.63 38.08 38.66 38.03 37.54 36.04 34.70 34.03 32.71 30.59 29.34 28.85 28.13 28.56
Gross Operating Profit 96,131 97,214 94,601 100,617 100,486 99,246 94,242 94,961 96,376 101,831 107,667 117,769 122,608 125,508 133,192 143,099 151,805 158,295 167,031 168,659
Change (%) 1.13 -2.69 6.36 -0.13 -1.23 -5.04 0.76 1.49 5.66 5.73 9.38 4.11 2.37 6.12 7.44 6.08 4.28 5.52 0.97
% of Revenue 64.73 64.78 65.68 64.44 63.85 62.97 62.37 61.92 61.34 61.97 62.46 63.96 65.30 65.97 68.14 69.41 70.66 71.15 71.87 71.44
SG&A 33,738 33,882 31,250 33,716 34,155 33,869 32,498 33,072 33,594 34,572 37,649 38,143 38,955 40,238 42,457 43,988 45,251 46,543 51,545 52,762
Change (%) 0.43 -7.77 7.89 1.30 -0.84 -4.05 1.77 1.58 2.91 8.90 1.31 2.13 3.29 5.51 3.61 2.87 2.86 10.75 2.36
% of Revenue 22.72 22.58 21.70 21.59 21.70 21.49 21.51 21.56 21.38 21.04 21.84 20.72 20.75 21.15 21.72 21.34 21.06 20.92 22.18 22.35
R&D
Change (%)
% of Revenue
OpEx 123,757 124,304 116,679 128,563 129,454 130,684 126,358 128,530 133,166 138,393 143,846 147,512 147,391 147,694 150,082 155,348 161,003 167,752 172,813 177,481
Change (%) 0.44 -6.13 10.19 0.69 0.95 -3.31 1.72 3.61 3.93 3.94 2.55 -0.08 0.21 1.62 3.51 3.64 4.19 3.02 2.70
% of Revenue 83.34 82.83 81.01 82.34 82.25 82.92 83.63 83.81 84.76 84.21 83.45 80.11 78.50 77.64 76.78 75.36 74.94 75.40 74.36 75.18
Operating Income 24,744 25,772 27,356 27,567 27,935 26,925 24,741 24,831 23,944 25,942 28,528 36,615 40,369 42,547 45,392 50,805 53,832 54,722 59,602 58,596
Change (%) 4.15 6.15 0.77 1.33 -3.62 -8.11 0.36 -3.57 8.34 9.97 28.35 10.25 5.40 6.69 11.93 5.96 1.65 8.92 -1.69
% of Revenue 16.66 17.17 18.99 17.66 17.75 17.08 16.37 16.19 15.24 15.79 16.55 19.89 21.50 22.36 23.22 24.64 25.06 24.60 25.64 24.82
Interest Expense -2,582 -2,045 -1,559 -1,200 -1,049 -1,089 -1,144 -1,214 -1,264 -1,281 -1,255 -1,093 -829 -699 -440 -581 -745 -867 -935 -1,460
Change (%) -20.80 -23.77 -23.03 -12.58 3.81 5.05 6.12 4.12 1.34 -2.03 -12.91 -24.15 -15.68 -37.05 32.05 28.23 16.38 7.84 56.15
% of Revenue -1.74 -1.36 -1.08 -0.77 -0.67 -0.69 -0.76 -0.79 -0.80 -0.78 -0.73 -0.59 -0.44 -0.37 -0.23 -0.28 -0.35 -0.39 -0.40 -0.62
Net Income 16,932 18,465 21,336 22,668 47,957 47,689 44,873 44,184 19,386 20,611 19,603 25,289 28,071 29,738 38,595 41,925 43,030 45,369 45,255 45,724
Change (%) 9.05 15.55 6.24 111.56 -0.56 -5.90 -1.54 -56.12 6.32 -4.89 29.01 11.00 5.94 29.78 8.63 2.64 5.44 -0.25 1.04
% of Revenue 11.40 12.30 14.81 14.52 30.47 30.26 29.70 28.81 12.34 12.54 11.37 13.73 14.95 15.63 19.74 20.34 20.03 20.39 19.47 19.37

Source: Capital IQ

Other Listings
IN:ZYDUSLIFE ₹ 1,014.15
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista